Stock Financial Ratios, Dividends, Split History

WSR / Whitestone REIT financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)504.20
Enterprise Value ($M)1,180.32
Book Value ($M)343.44
Book Value / Share8.63
Price / Book1.47
NCAV / Sharen/a
Price / NCAVn/a
Share Statistics
Common Shares Outstanding 39,223,591
Weighted Average Number Of Diluted Shares Outstanding 36,255,000
Preferred Stock Shares Outstanding 0
Common Stock Shares Outstanding 39,221,773
Weighted Average Number Of Shares Outstanding Basic 35,428,000
Scoring Models
Piotroski F-Score3.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.01
Return on Assets (ROA)0.01
Return on Equity (ROE)0.03
Balance Sheet (mrq) ($M)
Quick Ration/a
Current Ration/a
Income Statement (mra) ($M)
Tenant Reimbursement And Other Revenue31,391,000.00
Real Estate Revenue Net125,959,000.00
Net Income8.87
Earnings Per Share Diluted0.22
Earnings Per Share Basic0.22
Cash Flow Statement (mra) ($M)
Cash From Operations40.96
Cash from Investing-142.50
Cash from Financing40.96
Identifiers and Descriptors
Central Index Key (CIK)1175535
Related CUSIPS
966084904 966084954

Split History

Stock splits are used by Whitestone REIT to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

CYTX: Cytori Therapeutics Analysis and Research Report

9h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

Related News Stories

Should You Still Buy This 9.1%-Yielding, Monthly-Paying REIT?

2018-07-02 seekingalpha
That being said, Whitestone REIT has a rather thin margin of dividend safety, and the company has released a soft core FFO outlook for 2018. (1-0)

3 High Yield Investments, But Only 1 Has A Bright Future

2018-06-26 seekingalpha
Regency Centers is a strong company with great management and finally dipped into the buy zone. (95-0)

151 Monthly Paying Dividend SML Equities And 69 Funds For June

2018-06-21 seekingalpha
Here's your June 2018 Monthly-Paid (MoPay) Small-Mid-Large Cap Dividend, Yield, Upsides, and Net Gains reports. Nano-Cap MoPays are not listed. (18-4)

The 7 Best Dividend Stocks for Monthly Income

2018-06-20 investorplace
Monthly dividend stocks are popular with investors – and with good reason. Monthly payments line up better with monthly bills, particularly for retirees living off investment income. Over time, there’s even a modest incremental benefit from compounding, particularly for investors successfully using DRIP plans. (44-1)

Whitestone REIT: Nothing Changing

2018-05-18 seekingalpha
The unofficial vote count is in for the Whitestone REIT (WSR) proxy battle. Preliminary results suggest that KBS's nominees were defeated and the old guard will remain solidly in control at WSR. (1-0)

CUSIP: 966084204